CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities:
Net income	$ 255,745	$ 121,911
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Stock-based compensation	435,062	425,635
Gain on strategic investments and marketable securities, net	(257,616)	(134,647)
Debt inducement expense	0	28,584
Depreciation and amortization	96,059	56,216
Provision for bad debts and inventory	7,208	8,828
Deferred income taxes	36,093	(53,696)
Noncash lease expense	10,962	7,026
Other noncash items	27,913	8,904
Change in assets and liabilities:
Receivables and contract assets	(448,926)	(366,053)
Inventory	(238,141)	(58,177)
Deferred revenue	85,227	21,556
Accounts payable, accrued and other liabilities	108,786	44,730
Prepaid expenses and other assets	(110,125)	(116,713)
Net cash provided by (used in) operating activities	8,247	(5,896)
Cash flows from investing activities:
Purchases of investments	(490,743)	(2,045,738)
Business combinations, net of cash acquired	(552,018)	(22,809)
Proceeds from call, maturity, and sale of investments	509,430	1,644,556
Purchases of property and equipment	(82,762)	(74,450)
Other, net	(2,201)	(49)
Net cash used in investing activities	(618,294)	(498,490)
Cash flows from financing activities:
Net proceeds from equity offering	100,259	362,241
Proceeds from issuance of notes	1,150,000	1,750,000
Purchase of capped calls related to the 2031 convertible senior notes	(114,885)	0
Principal payments for conversion and redemption of convertible debt	(81,110)	(407,472)
Income and payroll tax payments for net-settled stock awards	(167,156)	(209,631)
Payments to third parties for debt issuance, amendments, conversion, redemption and capped call activity	(17,311)	(26,888)
Other, net	671	(226)
Net cash provided by financing activities	870,468	1,468,024
Effect of exchange rate changes on cash and cash equivalents	(1,786)	5,741
Net change in cash and cash equivalents	258,635	969,379
Cash and cash equivalents and restricted cash, beginning of period	1,213,393	466,763
Cash and cash equivalents and restricted cash, end of period	1,472,028	1,436,142
Supplemental disclosures:
Cash and cash equivalents	1,458,817	1,423,871
Restricted cash	13,211	12,271
Total cash, cash equivalents and restricted cash shown in the statements of cash flows	1,472,028	1,436,142
Cash paid for interest	108,187	56,468
Non-cash transactions:
Leased assets obtained in exchange for new operating lease liabilities	10,634	51,780
Property and equipment purchases in accounts payable and accrued liabilities	4,323	3,432
Expense for induced conversion of convertible debt, debt offering, revolver modifications and capped calls	2,607	31,570
Taxes withheld on stock-based awards included in accrued expenses	$ 105	$ 10,510